C07D 257/04
Five-membered rings
C07D257/04 (Five-membered rings) appears on 2,211 US grants and 1,649 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,211
- Published applications
- 1,649
- Assignees
- 823
- Inventors
- 5,669
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 34 | 0 |
| 1978 | 54 | 0 |
| 1979 | 33 | 0 |
| 1980 | 27 | 0 |
| 1981 | 71 | 0 |
| 1982 | 28 | 0 |
| 1983 | 28 | 0 |
| 1984 | 32 | 0 |
| 1985 | 43 | 0 |
| 1986 | 29 | 0 |
| 1987 | 36 | 0 |
| 1988 | 33 | 0 |
| 1989 | 49 | 0 |
| 1990 | 32 | 0 |
| 1991 | 45 | 0 |
| 1992 | 31 | 0 |
| 1993 | 44 | 0 |
| 1994 | 35 | 0 |
| 1995 | 38 | 0 |
| 1996 | 39 | 0 |
| 1997 | 48 | 0 |
| 1998 | 48 | 0 |
| 1999 | 53 | 0 |
| 2000 | 43 | 0 |
| 2001 | 46 | 6 |
| 2002 | 62 | 50 |
| 2003 | 43 | 73 |
| 2004 | 33 | 83 |
| 2005 | 40 | 83 |
| 2006 | 46 | 80 |
| 2007 | 35 | 89 |
| 2008 | 54 | 84 |
| 2009 | 54 | 78 |
| 2010 | 65 | 83 |
| 2011 | 60 | 59 |
| 2012 | 62 | 78 |
| 2013 | 65 | 67 |
| 2014 | 56 | 74 |
| 2015 | 55 | 70 |
| 2016 | 57 | 79 |
| 2017 | 80 | 61 |
| 2018 | 44 | 56 |
| 2019 | 42 | 60 |
| 2020 | 49 | 64 |
| 2021 | 42 | 61 |
| 2022 | 43 | 53 |
| 2023 | 27 | 55 |
| 2024 | 28 | 40 |
| 2025 | 25 | 36 |
| 2026 | 23 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Process for the manufacture of tetrazole derivatives29 Sep 2026US 12,747,217 B2Hoffmann-La Roche Inc.
- Liposomal formulations comprising AT1 receptor blockers and uses thereof25 Aug 2026US 12,714,669 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Herbicidal tetrazole compounds25 Aug 2026US 12,715,849 B2Syngenta Crop Protection AG
- Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1-modulators28 Jul 2026US 12,692,223 B2Grey Wolf Therapeutics Limited
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Herbicidal compounds24 Sep 2026US 2026/0285819 A1Syngenta Crop Protection AG
Most cited
By later US patents
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- Acyl compounds170US 5,399,578 ACiba-Geigy Corporation · 1995
- Photographic emulsions, elements and processes utilizing release compounds124US 4,248,962 AEastman Kodak Company · 1981
- Ligands for metabotropic glutamate receptors and inhibitors of NAALADase119US 6,528,499 B1Georgetown University · 2003
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998